logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10858358 B1

PDFFull Text
Date of Patent:
Dec. 08, 2020

Filed:

Sep. 27, 2019

S1pr2 antagonists and uses therefor

Applicant:

Dalhousie University, Halifax, CA;

Inventors:

Christopher McMaster, Halifax, CA;

Gordon Simms, Halifax, CA;

Assignee:

DALHOUSIE UNIVERSITY, Halifax, CA;

Attorneys:

Polsinelli PC

Ron Galant

Primary Examiner:

Zinna Northington Davis

Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07C 317/48 (2006.01); C07C 229/24 (2006.01); C07F 9/38 (2006.01); C07J 31/00 (2006.01); A61P 27/02 (2006.01); A61P 9/10 (2006.01); A61P 25/28 (2006.01); A61P 9/00 (2006.01); A61P 3/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 19/10 (2006.01); A61K 31/444 (2006.01); C07F 9/09 (2006.01); C07F 9/6558 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/444 (2013.01); A61P 3/10 (2018.01); A61P 9/00 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01); A61P 15/00 (2018.01); A61P 19/10 (2018.01); A61P 25/00 (2018.01); A61P 25/28 (2018.01); A61P 27/02 (2018.01); C07C 229/24 (2013.01); C07C 317/48 (2013.01); C07F 9/3808 (2013.01); C07J 31/006 (2013.01); C07F 9/091 (2013.01); C07F 9/65583 (2013.01);
Abstract

Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also provided herein are (Z)-2-cyano-1-(2,6-dichloropyridin-4-yl)-3-((4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)methyl)guanidine and analogs thereof, and their use in treating retinopathies and diseases characterized by insufficient angiogenesis.

Find Patent Forward Citations

McMaster, Christopher. (2020). S1pr2 antagonists and uses therefor (U.S. Patent No. 10858358). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10858358

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…